Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
ACELRX PHARMA
(NQ:
ACRX
)
6.680
USD
-0.510 (-7.09%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
7.260
Bid (Size)
6.650 (100)
Ask (Size)
6.680 (200)
Prev. Close
7.190
Today's Range
6.500 - 7.260
52wk Range
2.270 - 7.300
Shares Outstanding
37,237,319
Dividend Yield
N/A
Top News
More News
AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
May 16, 2013
from
PR Newswire
AcelRx Pharmaceuticals Reports First Quarter 2013 Financial Results
May 08, 2013
from
PR Newswire
More News
Read More
AcelRx Pharmaceuticals to Hold First Quarter 2013 Financial Results Conference Call and Webcast on May 8, 2013
May 03, 2013
from
PR Newswire
AcelRx Pharmaceuticals Presents Positive Clinical Data for the Sufentanil NanoTab PCA System at ASRA Medical Meeting
May 02, 2013
from
PR Newswire
Top-line Data Show AcelRx Pharmaceuticals' ARX-04 Achieves Primary Endpoint in Dose-Finding Phase 2 Clinical Trial
April 24, 2013
from
PR Newswire
UPDATE: Jefferies Initiates AcelRx Pharmaceuticals with Buy on Expected FDA Approval for ARX-01
April 08, 2013
category
Benzinga
,
ACRX
,
Initiation
, and 3 more.
from
Latest Articles from Benzinga.com
Benzinga's Top Initiations
April 08, 2013
category
Benzinga
,
HPTX
,
ACRX
, and 5 more.
from
Latest Articles from Benzinga.com
Jefferies Starts AcelRx Pharmaceuticals (ACRX) at Buy
April 08, 2013
from
StreetInsider.com News Articles
Significant Catalysts And Company PR Error Present Significant Opportunity In AcelRx Pharmaceuticals
March 20, 2013
category
Pharmaceuticals
from
Trefis
AcelRx Pharmaceuticals (ACRX) Posts Q4 Loss of 41c/Share
March 12, 2013
from
StreetInsider.com News Articles
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here